(Q34335675)

1 August 2017

1 reference

title

The role of cyclooxygenase-2 in prostate cancer (English)

1 reference

1 August 2017

1 reference

Kirschenbaum A

1 reference

1 August 2017

Liu X

series ordinal

1 reference

1 August 2017

Yao S

series ordinal

1 reference

1 August 2017

Levine AC

series ordinal

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

issue

2 Suppl 1

1 reference

1 August 2017

page(s)

127-131

1 reference

Primary response genes induced by growth factors and tumor promoters

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Self-promotion? Intimate connections between APC and prostaglandin H synthase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

The role of prostaglandin synthesis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

PGE2 and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Host cyclooxygenase-2 modulates carcinoma growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Up-Regulation of Cyclooxygenase-2 by Product-Prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Prostacyclin in prostatic cancer: a better marker than bone scan or serum acid phosphatase?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Increased phospholipid fatty acid remodeling in human and rat prostatic adenocarcinoma tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Non-steroidal anti-inflammatory drugs and prostate cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Mutagenesis and carcinogenesis: endogenous and exogenous factors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Histology and cellular kinetics of prostatic atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Origins of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Expression of cyclooxygenase-2 protein in gastric adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901255-9

7 January 2021

10.1016/S0090-4295(01)01255-9

Identifiers

DOI

1 reference

1 August 2017

1 reference